Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1941516
PUBLISHER: Grand View Research | PRODUCT CODE: 1941516
Antifungal Drugs Market Size, Share & Trends Analysis Report By Drug Class (Azoles, Polyenes, Allylamines, Echinocandins), By Indication, By Dosage Form, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Antifungal Drugs Market Summary
The global antifungal drugs market size was estimated at USD 16.93 billion in 2025 and is projected to reach USD 23.39 billion by 2033, growing at a CAGR of 4.19% from 2026 to 2033. The market is driven by the increasing prevalence of fungal infections, particularly among immunocompromised patients, and the rising demand for effective treatment options.
In addition, advancements in antifungal drug development and growing awareness contribute to market expansion. The global market is witnessing substantial growth, driven by the increasing incidence of fungal infections across both developed and developing regions. Hospital-associated infections (HAIs), particularly candidemia, are a major contributor to the rising demand for antifungal treatments. According to the World Health Organization (WHO) in 2024, fungal infections are responsible for a significant number of hospital-related infections worldwide, exacerbated by the increasing number of immunocompromised patients, such as those undergoing cancer treatments, organ transplants, or immunosuppressive therapies.
The growing global burden of such infections, especially in regions with expanding healthcare infrastructure, contributes to sustained demand for antifungal therapies. Furthermore, the spread of multidrug-resistant pathogens like Candida auris, identified as an urgent global health threat by the CDC in 2024, has heightened concerns and prompted efforts to develop new and more effective antifungal drugs. The persistent prevalence of superficial fungal infections, such as athlete's foot, onychomycosis, and vaginal candidiasis, also ensures a steady demand for both prescription and over-the-counter (OTC) antifungal treatments globally.
Technological advancements in antifungal drug development are a key factor shaping the market landscape. The approval of novel antifungal agents, such as rezafungin in 2023, is expected to expand the treatment options available for invasive fungal infections. This systemic antifungal, which allows for once-weekly dosing, has gained attention for its clinical and economic advantages, particularly in outpatient settings. In addition, the development of new therapeutic classes and agents, such as fosmanogepix, a novel Gwt1 inhibitor, and olorofim, an orotomide targeting resistant Aspergillus species, is addressing critical gaps in treatment, particularly for immunocompromised populations. These innovations, alongside the ongoing advancements in diagnostic technologies like molecular diagnostics, are improving pathogen identification and enabling more targeted treatments. As a result, the market is expanding as new therapies are introduced and integrated into clinical practice, offering greater efficacy and convenience for patients and healthcare systems alike.
Despite these advancements, the market faces significant challenges, primarily stemming from antifungal resistance and the high costs of treatment. Resistance to commonly used antifungal agents, such as azoles and echinocandins, is becoming increasingly prevalent. The CDC's 2024 report highlights the rapid rise of Candida auris infections, with resistance rates to fluconazole exceeding 90% in some regions, making it one of the most difficult pathogens to treat. This growing resistance undermines the effectiveness of established treatments and creates a demand for newer, more expensive antifungal agents. The high cost of novel therapies, such as rezafungin, and their limited accessibility in many regions, particularly in low- and middle-income countries, presents a significant barrier to market growth. Furthermore, diagnostic delays and limited access to advanced antifungal treatments in resource-constrained settings exacerbate the public health burden of fungal infections. While advancements in drug development offer hope, the ability to make these therapies accessible and affordable, especially in underserved markets, will be crucial for realizing the full market potential.
Global Antifungal Drugs Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global antifungal drugs market report based on drug class, indication, dosage form, distribution channel, and region:
- Drug Class Outlook (Revenue, USD Billion, 2021 - 2033)
- Azoles
- Echinocandins
- Polyenes
- Allylamines
- Others
- Indication Outlook (Revenue, USD Billion, 2021 - 2033)
- Dermatophytosis
- Aspergillosis
- Candidiasis
- Others
- Dosage Form Outlook (Revenue, USD Billion, 2021 - 2033)
- Oral Drugs
- Ointments
- Powders
- Others
- Distribution Channel Outlook (Revenue, USD Billion, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Others
- Regional Outlook (Revenue, USD Billion, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Product Code: GVR-1-68038-293-8
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Drug Class
- 1.2.2. Indication
- 1.2.3. Dosage Form
- 1.2.4. Distribution Channel
- 1.3. Estimates and Forecast Timeline
- 1.4. Research Methodology
- 1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
- 1.6. Information Analysis
- 1.6.1. Data Analysis Models
- 1.7. Market Formulation & Data Visualization
- 1.8. Model Details
- 1.8.1. Commodity Flow Analysis
- 1.9. List of Secondary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Antifungal Drugs Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
- 3.3.1.1. Supplier Power
- 3.3.1.2. Buyer Power
- 3.3.1.3. Substitution Threat
- 3.3.1.4. Threat of New Entrants
- 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTLE Analysis
- 3.3.3. Pipeline Analysis
- 3.3.4. Patent Expiry Analysis
- 3.3.5. Pricing Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
Chapter 4. Antifungal Drugs Market: Drug Class Business Analysis
- 4.1. Drug Class Market Share, 2025 & 2033
- 4.2. Drug Class Segment Dashboard
- 4.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2021 to 2033 (USD Billion)
- 4.4. Azoles
- 4.4.1. Azoles Market, 2021 - 2033 (USD Billion)
- 4.5. Echinocandins
- 4.5.1. Echinocandins Market, 2021 - 2033 (USD Billion)
- 4.6. Polyenes
- 4.6.1. Polyenes Market, 2021 - 2033 (USD Billion)
- 4.7. Allylamines
- 4.7.1. Allylamines Market, 2021 - 2033 (USD Billion)
- 4.8. Others
- 4.8.1. Other Drug Class Market, 2021 - 2033 (USD Billion)
Chapter 5. Antifungal Drugs Market: Indication Business Analysis
- 5.1. Indication Market Share, 2025 & 2033
- 5.2. Indication Segment Dashboard
- 5.3. Market Size & Forecasts and Trend Analysis, by Indication, 2021 to 2033 (USD Billion)
- 5.4. Dermatophytosis
- 5.4.1. Dermatophytosis Market, 2021 - 2033 (USD Billion)
- 5.5. Aspergillosis
- 5.5.1. Aspergillosis Market, 2021 - 2033 (USD Billion)
- 5.6. Candidiasis
- 5.6.1. Candidiasis Market, 2021 - 2033 (USD Billion)
- 5.7. Others
- 5.7.1. Others Market, 2021 - 2033 (USD Billion)
Chapter 6. Antifungal Drugs Market: Dosage Form Business Analysis
- 6.1. Dosage Form Market Share, 2025 & 2033
- 6.2. Dosage Form Segment Dashboard
- 6.3. Market Size & Forecasts and Trend Analysis, by Dosage Form, 2021 to 2033 (USD Billion)
- 6.4. Oral Drugs
- 6.4.1. Oral Drugs Market, 2021 - 2033 (USD Billion)
- 6.5. Ointments
- 6.5.1. Ointments Market, 2021 - 2033 (USD Billion)
- 6.6. Powders
- 6.6.1. Powders Market, 2021 - 2033 (USD Billion)
- 6.7. Others
- 6.7.1. Others Market, 2021 - 2033 (USD Billion)
Chapter 7. Antifungal Drugs Market: Distribution Channel Business Analysis
- 7.1. Distribution Channel Market Share, 2025 & 2033
- 7.2. Distribution Channel Segment Dashboard
- 7.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Billion)
- 7.4. Hospital Pharmacies
- 7.4.1. Hospital Pharmacies Market, 2021 - 2033 (USD Billion)
- 7.5. Retail Pharmacies
- 7.5.1. Retail Pharmacies Market, 2021 - 2033 (USD Billion)
- 7.6. Other Pharmacies
- 7.6.1. Other Pharmacies Market, 2021 - 2033 (USD Billion)
Chapter 8. Antifungal Drugs Market: Regional Estimates & Trend Analysis
- 8.1. Regional Market Share Analysis, 2025 & 2033
- 8.2. Regional Market Dashboard
- 8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
- 8.4. North America
- 8.4.1. North America Antifungal Drugs Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Billion)
- 8.4.2. U.S.
- 8.4.2.1. Key Country Dynamics
- 8.4.2.2. Target Disease Prevalence
- 8.4.2.3. Regulatory Framework
- 8.4.2.4. Reimbursement Framework
- 8.4.2.5. U.S. Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.4.3. Canada
- 8.4.3.1. Key Country Dynamics
- 8.4.3.2. Target Disease Prevalence
- 8.4.3.3. Regulatory Framework
- 8.4.3.4. Reimbursement Framework
- 8.4.3.5. U.S. Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.4.4. Mexico
- 8.4.4.1. Key Country Dynamics
- 8.4.4.2. Target Disease Prevalence
- 8.4.4.3. Regulatory Framework
- 8.4.4.4. Reimbursement Framework
- 8.4.4.5. Mexico Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.5. Europe
- 8.5.1. Europe Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.5.2. UK
- 8.5.2.1. Key Country Dynamics
- 8.5.2.2. Target Disease Prevalence
- 8.5.2.3. Regulatory Framework
- 8.5.2.4. Reimbursement Framework
- 8.5.2.5. UK Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.5.3. Germany
- 8.5.3.1. Key Country Dynamics
- 8.5.3.2. Target Disease Prevalence
- 8.5.3.3. Regulatory Framework
- 8.5.3.4. Reimbursement Framework
- 8.5.3.5. Germany Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.5.4. France
- 8.5.4.1. Key Country Dynamics
- 8.5.4.2. Target Disease Prevalence
- 8.5.4.3. Regulatory Framework
- 8.5.4.4. Reimbursement Framework
- 8.5.4.5. France Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.5.5. Italy
- 8.5.5.1. Key Country Dynamics
- 8.5.5.2. Target Disease Prevalence
- 8.5.5.3. Regulatory Framework
- 8.5.5.4. Reimbursement Framework
- 8.5.5.5. Italy Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.5.6. Spain
- 8.5.6.1. Key Country Dynamics
- 8.5.6.2. Target Disease Prevalence
- 8.5.6.3. Regulatory Framework
- 8.5.6.4. Reimbursement Framework
- 8.5.6.5. Spain Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.5.7. Denmark
- 8.5.7.1. Key Country Dynamics
- 8.5.7.2. Target Disease Prevalence
- 8.5.7.3. Regulatory Framework
- 8.5.7.4. Reimbursement Framework
- 8.5.7.5. Denmark Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.5.8. Sweden
- 8.5.8.1. Key Country Dynamics
- 8.5.8.2. Target Disease Prevalence
- 8.5.8.3. Regulatory Framework
- 8.5.8.4. Reimbursement Framework
- 8.5.8.5. Sweden Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.5.9. Norway
- 8.5.9.1. Key Country Dynamics
- 8.5.9.2. Target Disease Prevalence
- 8.5.9.3. Regulatory Framework
- 8.5.9.4. Reimbursement Framework
- 8.5.9.5. Norway Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.6. Asia Pacific
- 8.6.1. Asia Pacific Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.6.2. Japan
- 8.6.2.1. Key Country Dynamics
- 8.6.2.2. Target Disease Prevalence
- 8.6.2.3. Regulatory Framework
- 8.6.2.4. Reimbursement Framework
- 8.6.2.5. Japan Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.6.3. China
- 8.6.3.1. Key Country Dynamics
- 8.6.3.2. Target Disease Prevalence
- 8.6.3.3. Regulatory Framework
- 8.6.3.4. Reimbursement Framework
- 8.6.3.5. China Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.6.4. India
- 8.6.4.1. Key Country Dynamics
- 8.6.4.2. Target Disease Prevalence
- 8.6.4.3. Regulatory Framework
- 8.6.4.4. Reimbursement Framework
- 8.6.4.5. India Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.6.5. Australia
- 8.6.5.1. Key Country Dynamics
- 8.6.5.2. Target Disease Prevalence
- 8.6.5.3. Regulatory Framework
- 8.6.5.4. Reimbursement Framework
- 8.6.5.5. Australia Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.6.6. South Korea
- 8.6.6.1. Key Country Dynamics
- 8.6.6.2. Target Disease Prevalence
- 8.6.6.3. Regulatory Framework
- 8.6.6.4. Reimbursement Framework
- 8.6.6.5. South Korea Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.6.7. Thailand
- 8.6.7.1. Key Country Dynamics
- 8.6.7.2. Target Disease Prevalence
- 8.6.7.3. Regulatory Framework
- 8.6.7.4. Reimbursement Framework
- 8.6.7.5. Thailand Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.7. Latin America
- 8.7.1. Latin America Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.7.2. Brazil
- 8.7.2.1. Key Country Dynamics
- 8.7.2.2. Target Disease Prevalence
- 8.7.2.3. Regulatory Framework
- 8.7.2.4. Reimbursement Framework
- 8.7.2.5. Brazil Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.7.3. Argentina
- 8.7.3.1. Key Country Dynamics
- 8.7.3.2. Target Disease Prevalence
- 8.7.3.3. Regulatory Framework
- 8.7.3.4. Reimbursement Framework
- 8.7.3.5. Argentina Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.8. Middle East and Africa
- 8.8.1. Middle East and Africa Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.8.2. South Africa
- 8.8.2.1. Key Country Dynamics
- 8.8.2.2. Target Disease Prevalence
- 8.8.2.3. Regulatory Framework
- 8.8.2.4. Reimbursement Framework
- 8.8.2.5. South Africa Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.8.3. Saudi Arabia
- 8.8.3.1. Key Country Dynamics
- 8.8.3.2. Target Disease Prevalence
- 8.8.3.3. Regulatory Framework
- 8.8.3.4. Reimbursement Framework
- 8.8.3.5. Saudi Arabia Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.8.4. UAE
- 8.8.4.1. Key Country Dynamics
- 8.8.4.2. Target Disease Prevalence
- 8.8.4.3. Regulatory Framework
- 8.8.4.4. Reimbursement Framework
- 8.8.4.5. UAE Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
- 8.8.5. Kuwait
- 8.8.5.1. Key Country Dynamics
- 8.8.5.2. Target Disease Prevalence
- 8.8.5.3. Regulatory Framework
- 8.8.5.4. Reimbursement Framework
- 8.8.5.5. Kuwait Antifungal Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
Chapter 9. Competitive Landscape
- 9.1. Participant Overview
- 9.2. Company Market Position Analysis
- 9.3. Company Categorization
- 9.4. Strategy Mapping
- 9.5. Company Profiles/Listing
- 9.5.1. Bausch Health Companies Inc.
- 9.5.1.1. Overview
- 9.5.1.2. Financial Performance
- 9.5.1.3. Product Benchmarking
- 9.5.1.4. Strategic Initiatives
- 9.5.2. Pfizer, Inc.
- 9.5.2.1. Overview
- 9.5.2.2. Financial Performance
- 9.5.2.3. Product Benchmarking
- 9.5.2.4. Strategic Initiatives
- 9.5.3. Bayer AG
- 9.5.3.1. Overview
- 9.5.3.2. Financial Performance
- 9.5.3.3. Product Benchmarking
- 9.5.3.4. Strategic Initiatives
- 9.5.4. Sandoz
- 9.5.4.1. Overview
- 9.5.4.2. Financial Performance
- 9.5.4.3. Product Benchmarking
- 9.5.4.4. Strategic Initiatives
- 9.5.5. Merck & Co., Inc.
- 9.5.5.1. Overview
- 9.5.5.2. Financial Performance
- 9.5.5.3. Product Benchmarking
- 9.5.5.4. Strategic Initiatives
- 9.5.6. GSK plc.
- 9.5.6.1. Overview
- 9.5.6.2. Financial Performance
- 9.5.6.3. Product Benchmarking
- 9.5.6.4. Strategic Initiatives
- 9.5.7. Kenvue
- 9.5.7.1. Overview
- 9.5.7.2. Financial Performance
- 9.5.7.3. Product Benchmarking
- 9.5.7.4. Strategic Initiatives
- 9.5.8. GLENMARK
- 9.5.8.1. Overview
- 9.5.8.2. Financial Performance
- 9.5.8.3. Product Benchmarking
- 9.5.8.4. Strategic Initiatives
- 9.5.9. Janssen Pharmaceuticals
- 9.5.9.1. Overview
- 9.5.9.2. Financial Performance
- 9.5.9.3. Product Benchmarking
- 9.5.9.4. Strategic Initiatives
- 9.5.10. Astellas Pharma, Inc.
- 9.5.10.1. Overview
- 9.5.10.2. Financial Performance
- 9.5.10.3. Product Benchmarking
- 9.5.10.4. Strategic Initiatives
- 9.5.1. Bausch Health Companies Inc.
Product Code: GVR-1-68038-293-8
List of Tables
- Table 1 List of secondary sources
- Table 2 List of abbreviations
- Table 3 Global Antifungal drugs market, by region, 2021 - 2033 (USD Billion)
- Table 4 Global antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
- Table 5 Global antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
- Table 6 Global antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
- Table 7 Global antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
- Table 8 North America antifungal drugs market, by country, 2021 - 2033 (USD Billion)
- Table 9 North America antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
- Table 10 North America antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
- Table 11 North America antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
- Table 12 North America antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
- Table 13 US antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
- Table 14 US antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
- Table 15 US antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
- Table 16 US antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
- Table 17 Canada antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
- Table 18 Canada antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
- Table 19 Canada antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
- Table 20 Canada antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
- Table 21 Mexico antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
- Table 22 Mexico antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
- Table 23 Mexico antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
- Table 24 Mexico antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
- Table 25 Europe antifungal drugs market, by country, 2021 - 2033 (USD Billion)
- Table 26 Europe antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
- Table 27 Europe antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
- Table 28 Europe antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
- Table 29 Europe antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
- Table 30 UK antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
- Table 31 UK antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
- Table 32 UK antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
- Table 33 UK antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
- Table 34 Germany antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
- Table 35 Germany antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
- Table 36 Germany antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
- Table 37 Germany antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
- Table 38 France antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
- Table 39 France antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
- Table 40 France antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
- Table 41 France antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
- Table 42 Italy antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
- Table 43 Italy antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
- Table 44 Italy antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
- Table 45 Italy antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
- Table 46 Spain antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
- Table 47 Spain antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
- Table 48 Spain antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
- Table 49 Spain antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
- Table 50 Norway antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
- Table 51 Norway antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
- Table 52 Norway antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
- Table 53 Norway antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
- Table 54 Denmark antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
- Table 55 Denmark antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
- Table 56 Denmark antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
- Table 57 Denmark antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
- Table 58 Sweden antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
- Table 59 Sweden antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
- Table 60 Sweden antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
- Table 61 Sweden antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
- Table 62 Asia Pacific antifungal drugs market, by country, 2021 - 2033 (USD Billion)
- Table 63 Asia Pacific antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
- Table 64 Asia Pacific antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
- Table 65 Asia Pacific antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
- Table 66 Asia Pacific antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
- Table 67 Japan antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
- Table 68 Japan antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
- Table 69 Japan antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
- Table 70 Japan antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
- Table 71 China antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
- Table 72 China antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
- Table 73 China antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
- Table 74 China antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
- Table 75 India antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
- Table 76 India antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
- Table 77 India antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
- Table 78 India antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
- Table 79 Australia antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
- Table 80 Australia antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
- Table 81 Australia antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
- Table 82 Australia antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
- Table 83 South Korea antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
- Table 84 South Korea antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
- Table 85 South Korea antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
- Table 86 South Korea antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
- Table 87 Thailand antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
- Table 88 Thailand antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
- Table 89 Thailand antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
- Table 90 Thailand antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
- Table 91 Latin America antifungal drugs market, by country, 2021 - 2033 (USD Billion)
- Table 92 Latin America antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
- Table 93 Latin America antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
- Table 94 Latin America antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
- Table 95 Latin America antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
- Table 96 Brazil antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
- Table 97 Brazil antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
- Table 98 Brazil antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
- Table 99 Brazil antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
- Table 100 Argentina antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
- Table 101 Argentina antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
- Table 102 Argentina antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
- Table 103 Argentina antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
- Table 104 Middle East & Africa antifungal drugs market, by country, 2021 - 2033 (USD Billion)
- Table 105 Middle East & Africa antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
- Table 106 Middle East & Africa antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
- Table 107 Middle East & Africa antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
- Table 108 Middle East & Africa antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
- Table 109 South Africa antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
- Table 110 South Africa antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
- Table 111 South Africa antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
- Table 112 South Africa antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
- Table 113 Saudi Arabia antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
- Table 114 Saudi Arabia antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
- Table 115 Saudi Arabia antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
- Table 116 Saudi Arabia antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
- Table 117 UAE antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
- Table 118 UAE antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
- Table 119 UAE antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
- Table 120 UAE antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
- Table 121 Kuwait antifungal drugs market, by drug class, 2021 - 2033 (USD Billion)
- Table 122 Kuwait antifungal drugs market, by indication, 2021 - 2033 (USD Billion)
- Table 123 Kuwait antifungal drugs market, by dosage form, 2021 - 2033 (USD Billion)
- Table 124 Kuwait antifungal drugs market, by distribution channel, 2021 - 2033 (USD Billion)
List of Figures
- Fig. 1 Antifungal drugs market segmentation
- Fig. 2 Market research process
- Fig. 3 Data triangulation techniques
- Fig. 4 Primary research pattern
- Fig. 5 Market research approaches
- Fig. 6 Value-chain-based sizing & forecasting
- Fig. 7 Market formulation & validation
- Fig. 8 Market snapshot
- Fig. 9 Segment snapshot
- Fig. 10 Competitive landscape
- Fig. 11 Antifungal drugs market dynamics
- Fig. 12 Antifungal drugs market: Porter's five forces analysis
- Fig. 13 Antifungal drugs market: PESTLE analysis
- Fig. 14 Drug Class market, 2021 - 2033 (USD Billion)
- Fig. 15 Azoles market, 2021 - 2033 (USD Billion)
- Fig. 16 Echinocandins market, 2021 - 2033 (USD Billion)
- Fig. 17 Polyenes market, 2021 - 2033 (USD Billion)
- Fig. 18 Allylamines market, 2021 - 2033 (USD Billion)
- Fig. 19 Others market, 2021 - 2033 (USD Billion)
- Fig. 20 Indication market, 2021 - 2033 (USD Billion)
- Fig. 21 Dermatophytosis market, 2021 - 2033 (USD Billion)
- Fig. 22 Aspergillosis market, 2021 - 2033 (USD Billion)
- Fig. 23 Candidiasis market, 2021 - 2033 (USD Billion)
- Fig. 24 Others market, 2021 - 2033 (USD Billion)
- Fig. 25 Dosage Form market, 2021 - 2033 (USD Billion)
- Fig. 26 Oral Drugs market, 2021 - 2033 (USD Billion)
- Fig. 27 Ointments market, 2021 - 2033 (USD Billion)
- Fig. 28 Powders market, 2021 - 2033 (USD Billion)
- Fig. 29 Others market, 2021 - 2033 (USD Billion)
- Fig. 30 Distribution Channel market, 2021 - 2033 (USD Billion)
- Fig. 31 Hospital pharmacies market, 2021 - 2033 (USD Billion)
- Fig. 32 Retail pharmacies market, 2021 - 2033 (USD Billion)
- Fig. 33 Other pharmacies market, 2021 - 2033 (USD Billion)
- Fig. 34 Antifungal drugs market revenue, by region
- Fig. 35 Regional marketplace: Key takeaways
- Fig. 36 North America antifungal drugs market, 2021 - 2033 (USD Billion)
- Fig. 37 U.S. country dynamics
- Fig. 38 U.S. antifungal drugs market, 2021 - 2033 (USD Billion)
- Fig. 39 Canada country dynamics
- Fig. 40 Canada antifungal drugs market, 2021 - 2033 (USD Billion)
- Fig. 41 Mexico country dynamics
- Fig. 42 Mexico antifungal drugs market, 2021 - 2033 (USD Billion)
- Fig. 43 Europe antifungal drugs market, 2021 - 2033 (USD Billion)
- Fig. 44 UK country dynamics
- Fig. 45 UK antifungal drugs market, 2021 - 2033 (USD Billion)
- Fig. 46 Germany country dynamics
- Fig. 47 Germany antifungal drugs market, 2021 - 2033 (USD Billion)
- Fig. 48 France country dynamics
- Fig. 49 France antifungal drugs market, 2021 - 2033 (USD Billion)
- Fig. 50 Italy country dynamics
- Fig. 51 Italy antifungal drugs market, 2021 - 2033 (USD Billion)
- Fig. 52 Spain country dynamics
- Fig. 53 Spain antifungal drugs market, 2021 - 2033 (USD Billion)
- Fig. 54 Norway country dynamics
- Fig. 55 Norway antifungal drugs market, 2021 - 2033 (USD Billion)
- Fig. 56 Sweden country dynamics
- Fig. 57 Sweden antifungal drugs market, 2021 - 2033 (USD Billion)
- Fig. 58 Denmark country dynamics
- Fig. 59 Denmark antifungal drugs market, 2021 - 2033 (USD Billion)
- Fig. 60 Asia Pacific antifungal drugs market, 2021 - 2033 (USD Billion)
- Fig. 61 Japan country dynamics
- Fig. 62 Japan antifungal drugs market, 2021 - 2033 (USD Billion)
- Fig. 63 China country dynamics
- Fig. 64 China antifungal drugs market, 2021 - 2033 (USD Billion)
- Fig. 65 India country dynamics
- Fig. 66 India antifungal drugs market, 2021 - 2033 (USD Billion)
- Fig. 67 Australia country dynamics
- Fig. 68 Australia antifungal drugs market, 2021 - 2033 (USD Billion)
- Fig. 69 South Korea country dynamics
- Fig. 70 South Korea antifungal drugs market, 2021 - 2033 (USD Billion)
- Fig. 71 Thailand country dynamics
- Fig. 72 Thailand antifungal drugs market, 2021 - 2033 (USD Billion)
- Fig. 73 Latin America antifungal drugs market, 2021 - 2033 (USD Billion)
- Fig. 74 Brazil country dynamics
- Fig. 75 Brazil antifungal drugs market, 2021 - 2033 (USD Billion)
- Fig. 76 Argentina country dynamics
- Fig. 77 Argentina antifungal drugs market, 2021 - 2033 (USD Billion)
- Fig. 78 MEA antifungal drugs market, 2021 - 2033 (USD Billion)
- Fig. 79 South Africa country dynamics
- Fig. 80 South Africa antifungal drugs market, 2021 - 2033 (USD Billion)
- Fig. 81 Saudi Arabia country dynamics
- Fig. 82 Saudi Arabia antifungal drugs market, 2021 - 2033 (USD Billion)
- Fig. 83 UAE country dynamics
- Fig. 84 UAE antifungal drugs market, 2021 - 2033 (USD Billion)
- Fig. 85 Kuwait country dynamics
- Fig. 86 Kuwait antifungal drugs market, 2021 - 2033 (USD Billion)
- Fig. 87 Company categorization
- Fig. 88 Company market position analysis, 2024
- Fig. 89 Strategic framework
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.